N calculation for trial about PK superiority [Power / Sample Size]

posted by alejandro_jo1990 – Spain, 2022-09-01 16:40 (967 d 07:46 ago) – Posting: # 23252
Views: 4,737

Hello to all! first thanks for this wonderful forum, here a young MD, clinical pharmacologist recently moving from clinical trials conduct to design, tryinto apply my (modest) knowledge of clinical PK and biostatistics to phase I trial design. I was discussing with a former colleague. If we were to design a trial to try to support a change in SmPC for a certain product, ie. a faster absorption:

- If we were to demostrate in overall a faster absorption, we would need to design a superiority trial and calculate N based on expected diff in logCmax using logsd (difference or more conservative the higer Cmax maybe?). Suggested log to use a diff in means to calculate N and Cmax as is the parameter to include both extentand and rate of absorption (I deem Tmax as useless).

-If we were to demonstrate a faster absorption at X point (10 minutes), before Tmax, shall I need to use the differences in logAUC with same SD assessment? or concentration at 10 minutes would suffice (or maybe any approach is not correct at all).

I assume I would calculate N based on the difference in means as in any study.

PS. I swear I conducted an intensive research through the forum

BR
Alex

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
41 visitors (0 registered, 41 guests [including 8 identified bots]).
Forum time: 00:27 CEST (Europe/Vienna)

It is a well-known experience that the only truly enjoyable and
profitable way of studying mathematics is the method of
“filling in details” by one’s own efforts.    Cornelius Lanczos

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5